A pilot, open study on the treatment of refractory schizophrenia with risperidone and clozapine
- 1 May 1995
- journal article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 10 (3) , 231-234
- https://doi.org/10.1002/hup.470100310
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Selective actions of the novel atypical antipsychotic drug amperozide in the limbic forebrainEuropean Neuropsychopharmacology, 1994
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- Survey on the pharmacodynamics of the new antipsychotic risperidonePsychopharmacology, 1994
- A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1993
- Treatment of the Neuroleptic-Nonresponsive Schizophrenic PatientSchizophrenia Bulletin, 1992
- Combined serotonin‐5‐HT2 and dopamine‐D2 antagonism in schizophrenia: Clinical, extrapyramidal and neuroendocrine response in a preliminary study with risperidone (R 64 766)Human Psychopharmacology: Clinical and Experimental, 1990
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Negative v Positive SchizophreniaArchives of General Psychiatry, 1982
- The Brief Psychiatric Rating ScalePsychological Reports, 1962